2015-08-06T09:20:13-05:00 2014-12-31 BDO USA LLP 7101 WISCONSIN AVE SUITE 800 BETHESDA MD 208144827 990 2014-01-01 311667995 CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY % ERIN HULTMAN FINANCE DIRECT CONQ 5714831700 2318 MILL ROAD Suite 800 ALEXANDRIA VA 22314 ERIN HULTMAN CPA FINANCE DIRECTOR 7038930600 2015-08-05 true Mike Sorrells P00001737 3016544900 2014 2016-04-25 22:37:26Z ALLEN LICHTER MD CEO 2318 MILL ROAD STE 800 ALEXANDRIA VA 22314 76450655 false X WWW.CONQUERCANCERFOUNDATION.ORG X 1999 VA CONQUERING CANCER WORLDWIDE BY FUNDING BREAKTHROUGH RESEARCH AND SHARING CUTTING-EDGE KNOWLEDGE. CCF'S VISION IS A WORLD FREE FROM THE FEAR OF CANCER. 16 15 0 95 0 0 22671350 36399446 0 0 1907790 2277668 0 0 24579140 38677114 13796349 15947927 0 0 0 0 0 0 1619615 4646888 5208075 18443237 21156002 6135903 17521112 47043311 64500410 5004208 5491485 42039103 59008925 X THE CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF) WAS STARTED BY CANCER DOCTORS OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO), TO FIGHT AND CONQUER ALL TYPES OF CANCER WORLDWIDE. CCF SEEKS DRAMATIC ADVANCES IN THE PREVENTION, TREATMENT AND CURE OF CANCER - ALL TYPES OF CANCER - WHEREVER THEY OCCUR BY FUNDING BREAKTHROUGH RESEARCH, PATIENT INFORMATION, PROFESSIONAL EDUCATION, AND QUALITY IMPROVEMENT PROGRAMS. CCF DISTINGUISHES ITSELF THROUGH ITS UNMATCHED REACH AND EXPERTISE. WE FOCUS ON EVERY MOMENT THAT CANCER TOUCHES PEOPLES LIVES, FROM PREVENTION TO END-OF-LIFE CARE, AND WE ADDRESS NEARLY EVERY CANCER TYPE, INCLUDING RARE FORMS. CCF DRAWS ON THE EXPERTISE OF THE GLOBAL NETWORK OF ASCO, WITH MORE THAN 35,000 ONCOLOGY PROFESSIONAL MEMBERS WHO TREAT PATIENTS WITH CANCER EVERY DAY AND LEAD THE SEARCH FOR NEW CURES. THESE PROFESSIONALS ARE THE WORLDS MOST TRUSTED AND CREDIBLE SOURCE OF CANCER KNOWLEDGE AND EDUCATION. CCFS NETWORK AND PROGRAMS ARE GLOB false false 7833703 6523577 PROFESSIONAL EDUCATION - WE HELP ONCOLOGISTS WORLDWIDE STAY UP TO DATE ON THE LATEST DEVELOPMENTS AND DISCOVERIES IN CANCER KNOWLEDGE. CCF SUPPORTS THE EFFORTS OF ASCO TO PROVIDE THE LATEST INFORMATION AND PROVIDE EDUCATION TO PHYSICIANS, RESEARCHERS AND CAREGIVERS. THIS WORK PROVIDES A DIRECT IMPACT AND BENEFIT TO EVERY CANCER PATIENT IN THE U.S. AND AROUND THE WORLD BY DEVELOPING AND COMMUNICATING THE MOST ADVANCED TREATMENT PROTOCOLS DEVELOPED BY ASCO PHYSICIANS. FUNDS FROM CCF ARE USED TO SUPPORT ASCO'S COMPREHENSIVE SCIENTIFIC AND EDUCATIONAL PROGRAMS THAT PROVIDE THE LATEST DATA TO CANCER DOCTORS AND OTHER HEALTHCARE PROFESSIONALS WORLDWIDE THROUGH BOTH LIVE MEETINGS AND PRINT AND ELECTRONIC EDUCATION OFFERINGS. HIGHLIGHTS OF THE PROFESSIONAL EDUCATIONAL AND SCIENTIFIC MEETINGS SUPPORTED BY CCF AND PRESENTED TO THE PUBLIC IN 2014 INCLUDE THE FOLLOWING: 1) THE ASCO ANNUAL MEETING FEATURED MORE THAN 400 EDUCATIONAL AND SCIENTIFIC SESSIONS. OVER 5,400 ABSTRACTS WERE PRESENTED OR PUBLISHED. THE ASCO ANNUAL MEETING IS CONSIDERED THE PREMIER EDUCATIONAL AND SCIENTIFIC EVENT IN THE ONCOLOGY COMMUNITY AND ATTRACTS MORE THAN 34,000 ATTENDEES WORLDWIDE. THE MEETING IS DESIGNED TO ADVANCE THE EDUCATION OF PHYSICIANS AND OTHER PROFESSIONALS INVOLVED IN MULTIDISCIPLINARY CLINICAL CANCER CARE, TO SUPPORT THE DEVELOPMENT OF CLINICAL CANCER RESEARCHERS AND TO FACILITATE THE DELIVERY OF HIGH-QUALITY HEALTH CARE TO PATIENTS WITH CANCER. SESSIONS ARE DESIGNED TO PROVIDE MEETING ATTENDEES OPTIMUM LEARNING EXPERIENCES THROUGH DISEASE-SPECIFIC TOPICS AND ONCOLOGY-RELATED SUBJECTS. 2) QUALITY CARE SYMPOSIUM IS A TWO-DAY NATIONAL SYMPOSIUM FOCUSING ON INNOVATIVE STRATEGIES TO ADVANCE THE AREAS OF QUALITY MEASUREMENT, QUALITY IMPROVEMENT, PATIENT OUTCOMES, COMPARATIVE EFFECTIVENESS RESEARCH AND THE ELIMINATION OF DISPARITIES IN THE PREVENTION, DIAGNOSIS AND TREATMENT OF CANCER IN THE UNITED STATES. THE OVERARCHING GOAL IS TO IMPROVE THE HEALTH OF ALL INDIVIDUALS WITH CANCER, THOSE AT INCREASED RISK OF DEVELOPING CANCER, AND CANCER SURVIVORS. 3) GASTROINTESTINAL CANCERS (GI) SYMPOSIUM - THE ANNUAL GI SYMPOSIUM IS THE PREMIERE MULTIDISCIPLINARY GI CANCER SCIENTIFIC AND EDUCATIONAL MEETING OFFERING THE MOST UP-TO-DATE STRATEGIES IN PREVENTION, SCREENING, AND TREATMENT OF GASTROINTESTINAL CANCERS. THE SYMPOSIUM IS JOINTLY DEVELOPED BY THE AMERICAN GASTROENTEROLOGICAL ASSOCIATION INSTITUTE, ASCO, THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY, AND THE SOCIETY OF SURGICAL ONCOLOGY. 4) GENITOURINARY CANCERS (GU) SYMPOSIUM - THE ANNUAL GU SYMPOSIUM IS THE PREEMINENT GENITOURINARY CANCER SCIENTIFIC AND EDUCATIONAL MEETING PROVIDING THE LATEST STRATEGIES IN SCREENING, DIAGNOSIS, TREATMENT, MANAGEMENT AND CONTROVERSIES IN THE FIELD OF GENITOURINARY CANCERS. THE SYMPOSIUM IS JOINTLY DEVELOPED BY ASCO, THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY, AND THE SOCIETY OF UROLOGIC ONCOLOGY. 5) BREAST CANCER (BCS) SYMPOSIUM - THE ANNUAL BREAST CANCER SYMPOSIUM FEATURES PRESENTATIONS ON THE LATEST MULTIDISCIPLINARY RESEARCH FROM SELECTED THEME-BASED TRANSLATIONAL AND CLINICAL ABSTRACTS, AS WELL AS RELATED EDUCATIONAL SESSIONS. THIS SYMPOSIUM OFFERS AN OPPORTUNITY FOR CLINICALLY RELEVANT, IN-DEPTH DISCUSSIONS OF HOW AND WHEN TO TRANSLATE NEW FINDINGS INTO PATIENT CARE ULTIMATELY TO IMPROVE OUTCOMES FOR PATIENTS REQUIRING BREAST CANCER THERAPY. THE MEETING IS JOINTLY DEVELOPED BY ASCO, THE AMERICAN SOCIETY OF BREAST DISEASE, THE AMERICAN SOCIETY OF BREAST SURGEONS, THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY, THE NATIONAL CONSORTIUM OF BREAST CENTERS, INC., THE SOCIETY OF SURGICAL ONCOLOGY. 6) BEST OF ASCO HELD IN BOSTON, MA, CHICAGO, IL, AND SEATTLE, WA - THE BEST OF ASCO MEETING PROGRAM CONDENSES HIGHLIGHTS FROM THE ASCO ANNUAL MEETING INTO A TWO DAY EDUCATIONAL MEETING, WHICH PROVIDES A UNIQUE, INTIMATE FORUM FOR THE PRESENTATION AND DISCUSSION OF THE PRACTICE-CHANGING SCIENCE AND EDUCATIONAL HIGHLIGHTS THAT WERE PRESENTED. A PANEL OF ASCO EXPERTS SELECTS ABSTRACTS THAT HIGHLIGHT THE IMPORTANT SCIENTIFIC INFORMATION TO CREATE THE BEST OF ASCO MEETING PROGRAM. THIS PROGRAM PROVIDES ACCESS TO THE MOST CUTTING-EDGE, PRACTICE-CHANGING RESEARCH PRESENTED AT THE MEETING IN A RESPONSIBLE, PEER-REVIEWED MANNER. 7) ASCO/AACR METHODS WORKSHOP - THIS INTENSIVE ANNUAL WORKSHOP, IN PARTNERSHIP WITH THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, BRINGS TOGETHER CLINICAL FELLOWS AND JUNIOR FACULTY CLINICAL RESEARCHERS IN ALL CANCER TYPES. THE WORKSHOP TEACHES ATTENDEES HOW TO PLAN AND CONDUCT AN EFFECTIVE CLINICAL TRIAL. THE OVERALL GOAL OF THE WORKSHOP IS TO INCREASE THE RELIABILITY AND EFFECTIVENESS OF CLINICAL TRIALS ULTIMATELY LEADING TO BETTER PATIENT CARE. 8) PALLIATIVE CARE IN ONCOLOGY SYMPOSIUM - THE PALLIATIVE CARE IN ONCOLOGY SYMPOSIUM IS AN EDUCATIONAL OPPORTUNITY FOR ONCOLOGY PROFESSIONALS THAT PROVIDES OPPORTUNITIES FOR ATTENDEES TO LEARN HOW TO INTEGRATE PALLIATIVE CARE SKILLS INTO CANCER CARE ACROSS THE TRAJECTORY OF THE ILLNESS. THE SYMPOSIUM IS COSPONSORED BY FOUR LEADING MEDICAL SPECIALTY SOCIETIES: THE AMERICAN ACADEMY OF HOSPICE AND PALLIATIVE MEDICINE (AAHPM), THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO), THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO) AND THE MULTINATIONAL ASSOCIATION OF SUPPORTIVE CARE IN CANCER (MASCC). 9) HIGHLIGHTS OF PRINT AND ELECTRONIC PROFESSIONAL EDUCATION MATERIALS SUPPORTED BY CCF AND AVAILABLE TO THE PUBLIC IN 2014 INCLUDE THE FOLLOWING: 10) PROCEEDINGS - THE PROCEEDINGS PUBLICATIONS FOR THE ASCO ANNUAL MEETING AND SELECT COSPONSORED THEMATIC SYMPOSIA CONTAIN ALL THE ABSTRACTS SELECTED FOR PRESENTATION AT THE LIVE EDUCATIONAL MEETING AND ALLOWS THOSE NOT ABLE TO ATTEND ACCESS TO THE GROUND-BREAKING ABSTRACTS THAT WERE PRESENTED. 11) EDUCATIONAL BOOKS -THE ASCO ANNUAL MEETING EDUCATIONAL BOOK IS THE COMPREHENSIVE RESOURCE FOR EDUCATION SESSION MATERIALS FROM THE ASCO ANNUAL MEETING, ALLOWING THE ENTIRE ONCOLOGY COMMUNITY TO BENEFIT FROM DISCUSSIONS OF CRITICAL RESEARCH UPDATES IN A POINT-OF-CARE CONTEXT. MANUSCRIPTS DISCUSS THE CURRENT STANDARDS OF CARE AND EXISTING TECHNOLOGIES BUT ALSO LOOK TOWARD THE FUTURE, DISCUSSING RESEARCH IMPROVEMENTS AND TRENDS AND TREATMENTS STILL ON THE HORIZON. 12) ABSTRACTS ON ASCO.ORG - ABSTRACTS ON ASCO.ORG PROVIDE THE RESULTS OF THE LATEST CLINICAL CANCER RESEARCH TO HEALTHCARE PROFESSIONALS INVOLVED IN MULTIDISCIPLINARY CLINICAL CANCER CARE. THE ABSTRACTS ON ASCO.ORG COMPRISE ASCO'S COMPREHENSIVE ONLINE DATABASE OF ONCOLOGY-RELATED RESEARCH ABSTRACTS FROM ASCO SCIENTIFIC AND EDUCATIONAL MEETINGS DATING BACK TO 1995. 13) VIRTUAL MEETINGS ON ASCO.ORG - THE ASCO VIRTUAL MEETING INTERFACE USES THE LATEST TECHNOLOGY TO ALLOW USERS TO VIEW AND REVIEW SESSIONS FROM THE ASCO ANNUAL MEETING AND CO-SPONSORED THEMATIC SYMPOSIA. VIEWERS CAN STAY ABREAST OF THE LATEST ONCOLOGY DEVELOPMENTS, VIEW MEETING SESSIONS THAT THEY WERE UNABLE TO ATTEND, OR REVIEW PRESENTATIONS AT THE TIME AND PLACE MOST CONVENIENT FOR THEM - AT HOME, ON THE ROAD, OR IN THE OFFICE. VIRTUAL MEETING FEATURES MORE THAN 25,000 ORAL PRESENTATIONS, ABSTRACTS, AND POSTERS FROM MEETINGS DATING BACK TO 1999 - THE MOST COMPREHENSIVE COLLECTION OF ONCOLOGY-RELATED MULTIMEDIA (SLIDES AND AUDIO) LECTURES AVAILABLE ON THE WEB. EACH SESSION INCLUDED ON VIRTUAL MEETING IS BASED ON THE ORIGINAL LEARNING OBJECTIVES. SESSION PRESENTATIONS ARE AVAILABLE IN MULTIPLE FORMATS AND INCLUDE LISTS OF RELATED ABSTRACTS, PRESENTATIONS, ASCO EDUCATIONAL BOOK ARTICLES, AND PUBMED CITATIONS. PRESENTATIONS ARE CAPTURED USING ONE OR A COMBINATION OF THE FOLLOWING: VIDEO, AUDIO, POWERPOINT PRESENTATIONS, AND/OR TEXT ABSTRACTS AND ARE POSTED ONLINE AS THEY BECOME AVAILABLE. SESSIONS CAPTURED AT THE LIVE MEETINGS ARE POSTED WITHIN 24 HOURS OF A SESSION'S COMPLETION. 14) ONLINE PORTALS - ASCO WEBSITES PLAY AN IMPORTANT ROLE IN EDUCATING ASCO MEMBERS AS WELL AS THE BROADER CANCER CARE COMMUNITY. ASCO'S DISEASE-SPECIFIC "CANCER PORTALS" ARE ORGANIZED THEMATICALLY FOR EASY ACCESS AND USAGE, ARE ACCESSIBLE FROM THE ASCO.ORG HOMEPAGE, A DIRECT URL, OTHER AREAS OF THE WEBSITE AND FROM SEARCH QUERY RESULTS.THE PORTALS ARE RESOURCES FOR PHYSICIANS TO DISCOVER THE LATEST FINDINGS IN VARIOUS AREAS OF CANCER RESEARCH THROUGH SCIENTIFIC ABSTRACTS, VIDEOS, LINKED ARTICLES, AND OTHER MATERIALS. THEY PROVIDE IMMEDIATE, STREAMLINED ACCESS TO A VAST AMOUNT OF EDUCATIONAL CONTENT ON ASCO.ORG AND ONLINE NAVIGATION AND ADVANCED SEARCH CAPABILITIES. DISEASE SPECIFIC PORTALS ARE AVAILABLE IN: BREAST CANCER, PROSTATE CANCER, GENITOURINARY CANCERS, GASTROINTESTINAL CANCER, HEAD AND NECK CANCERS, HEMTOLOGIC MALIGNANCIES, GYNECOLOGIC CANCERS, LUNG CANCER AND SARCOMA, . THE INFORMATION GENERATED FROM ASCO'S FAMILY OF WEBSITES TO THE CANCER PORTALS IS TRANSFERRED SEAMLESSLY TO USERS IN AN EASY-TO-BROWSE FORMAT. 15) ASCO UNIVERSITY - ASCO UNIVERSITY IS AN ONLINE PLATFORM THAT PROVIDES EDUCATION FOR ONCOLOGY PROFESSIONALS. COURSE CONTENT IS DEVELOPED AND PRESENTED BY RECOGNIZED EXPERTS. ASCO UNIVERSIT 7150108 5960350 RESEARCH - IN THIS AGE OF SCIENTIFIC PROMISE, FEDERAL FUNDS FOR CANCER RESEARCH ARE DECLINING. FULFILLING THE PROMISE OF TODAY'S ADVANCES REQUIRES FUNDING FOR RESEARCH PROJECTS AND SUPPORT FOR INVESTIGATORS WHO WISH TO PURSUE A CAREER IN CLINICAL AND TRANSLATIONAL CANCER RESEARCH. WITHOUT CONTINUED, WELL-TARGETED RESEARCH, THERE WOULD BE NO MEANINGFUL PROGRESS. CCF PRIDES ITSELF ON ITS STANDARDS FOR SCIENTIFIC RIGOR, IMPLEMENTING A MULTISTAGE PEER REVIEW PROCESS WITH THE PARTICIPATION OF GLOBALLY RECOGNIZED SCIENTISTS, ONCOLOGISTS, AND BIOSTATISTICIANS IN THE SELECTION OF MERITORIOUS RESEARCH FOR FUNDING. SINCE 1984, CCF AND ASCO HAVE FUNDED MORE THAN $90 MILLION IN CANCER RESEARCH GRANTS TO OVER A THOUSAND RECIPIENTS. IN 2014, CCF AWARDED 76 RESEARCH GRANTS. CCF FUNDS THE ENTIRE SPECTRUM OF RESEARCH ACTIVITIES RELATED TO CANCER PREVENTION, SCREENING, TREATMENT, AND OUTCOMES RESEARCH IN ALL CANCER TYPES, AND SUPPORTS PROGRESS BY FUNDING CANCER RESEARCHERS AT ALL STAGES OF THEIR CAREERS, ENABLING ONCOLOGY'S BEST AND BRIGHTEST TO PURSUE PROMISING RESEARCH. EACH YEAR, CCF FUNDS AND AWARDS MULTIPLE RESEARCH GRANTS DESIGNED TO HELP ATTRACT AND RETAIN THE BEST SCIENTIFIC MINDS IN CANCER RESEARCH AND TO SUPPORT THEIR EFFORTS. HIGHLIGHTS OF 2014 RESEARCH ACTIVITIES AND ACCOMPLISHMENTS INCLUDE: ADVANCED CLINICAL RESEARCH AWARD (ACRA) - $450,000 PROVIDED ONE (1) THREE-YEAR AWARD INTENDED TO FUND AN INVESTIGATOR COMMITTED TO CLINICAL CANCER RESEARCH AND WHO IS CONDUCTING ORIGINAL RESEARCH IN BREAST CANCER. CAREER DEVELOPMENT AWARD (CDA) - $2,000,000 PROVIDED TEN (10) THREE-YEAR AWARDS INTENDED TO SUPPORT CLINICAL RESEARCH OF CLINICAL INVESTIGATORS WHO HAVE RECEIVED THEIR INITIAL FACULTY APPOINTMENTS AND ARE ESTABLISHING INDEPENDENT CLINICAL CANCER RESEARCH PROGRAMS. YOUNG INVESTIGATOR AWARD (YIA) - $2,850,000 PROVIDED FIFTY-SEVEN (57) ONE-YEAR AWARDS DESIGNED TO ENCOURAGE AND PROMOTE HIGH-QUALITY RESEARCH IN CLINICAL ONCOLOGY BY PROVIDING FUNDS TO PROMISING INVESTIGATORS DURING THE TRANSITION FROM A FELLOWSHIP PROGRAM TO A FACULTY APPOINTMENT. LONG-TERM INTERNATIONAL FELLOWSHIP (LTIF) - $345,000 PROVIDED THREE (3)ONE-YEAR FELLOWSHIPS TO EARLY-CAREER ONCOLOGISTS FROM LOW TO MIDDLE INCOME COUNTRIES FOR THE SUPPORT AND RESOURCES NEEDED TO ADVANCE THEIR TRAINING BY DEEPENING THEIR RELATIONSHIPS WITH AMERICAN, CANADIAN, OR EUROPEAN COLLEAGUES AND THEIR U.S. ,CANADIAN, OR EU INSTITUTIONS. INTERNATIONAL INNOVATION GRANT - $80,000 PROVIDED FOUR (4) ONE-YEAR AWARDS IN SUPPORT OF NOVEL AND INNOVATIVE PROJECTS THAT CAN HAVE A SIGNIFICANT IMPACT ON CANCER CONTROL IN LOW- AND MIDDLE-INCOME COUNTRIES (LMCS). GIANNI BONADONNA BREAST CANCER RESEARCH FELLOWSHIP - $50,000 PROVIDED ONE (1) ONE-YEAR FELLOWSHIP THAT ENABLES AN EARLY-CAREER INVESTIGATOR TO UNDERTAKE A BREAST CANCER PROJECT UNDER THE MENTORSHIP OF THE GIANNI BONADONNA BREAST AWARD RECIPIENT. THE JAMES B. NACHMAN JUNIOR FACULTY AWARD IN PEDIATRIC ONCOLOGY WAS ESTABLISHED IN MEMORY OF JAMES B. NACHMAN, MD, AN INTERNATIONALLY RENOWNED PEDIATRIC CANCER EXPERT AND PEDIATRICS PROFESSOR. HE CHAIRED SEVERAL CHILDREN'S ONCOLOGY GROUP NATIONAL STUDY COMMITTEES AND WAS AN AUTHORITY IN THE MEDICAL MANAGEMENT OF CHILDHOOD CANCERS, ESPECIALLY LEUKEMIA AND LYMPHOMA. $3,000 PROVIDED FOR ONE JUNIOR FACULTY MEMBER WITH THE HIGHEST-SCORING ABSTRACT IN PEDIATRIC ONCOLOGY TO PRESENT THE ABSTRACT AT THE ASCO ANNUAL MEETING. CLINICAL TRIALS PARTICIPATION AWARD (CTPA)- $16,000 PROVIDED (8) AWARDS TO HONOR A PROGRAM THAT PUBLICLY HONORS HIGH-QUALITY, COMMUNITY-BASED ONCOLOGY PRACTICES AND INSTITUTIONS THAT ACTIVELY PARTICIPATE IN CLINICAL TRIALS RESEARCH. THIS PROGRAM IS DESIGNED TO ENCOURAGE ONCOLOGY PRACTICES THAT CURRENTLY PARTICIPATE IN CLINICAL TRIALS TO INCREASE THEIR ACCRUAL RATES IN ORDER TO SUPPORT CANCER RESEARCH AND ADVANCES. MERIT AWARDS- $178,900 PROVIDED FOR THE BRADLEY STUART BELLER MERIT AWARD AND 165 MERIT AWARDS WHICH PROMOTE CLINICAL RESEARCH BY AWARDING YOUNG SCIENTISTS WHOSE RESEARCH IS ADDRESSED IN HIGH QUALITY ABSTRACTS SUBMITTED TO ASCO MEETINGS WITH AN OPPORTUNITY TO PRESENT THEIR RESEARCH AND INTERACT WITH OTHER CLINICAL CANCER INVESTIGATORS AT ASCO SCIENTIFIC MEETINGS AND DISEASE-SPECIFIC SYMPOSIA. ONCOLOGY TRAINEE TRAVEL AWARDS- $43,920 PROVIDED FOR 36 TRAVEL AWARDS TO ALLOW FOR THE SUPPORT OF CONTINUING EDUCATION AND PROFESSIONAL DEVELOPMENT OF TRAINEE ONCOLOGISTS BY PROVIDING THEM INDIVIDUAL TRAVEL GRANTS TO DEFRAY TRAVEL EXPENSES FOR ATTENDING THE ASCO ANNUAL MEETING. CCF ALSO RAISED FUNDS FOR A NUMBER OF AWARDS PROVIDED BY ASCO IN ORDER TO RECOGNIZE AND ENCOURAGE INDIVIDUALS OR ORGANIZATIONS THAT HAVE MADE SIGNIFICANT CONTRIBUTIONS TO ASCO, THE PRACTICE OF CLINICAL ONCOLOGY, AND CANCER PATIENTS. HIGHLIGHTS OF AWARDS SUPPORTED BY THE FOUNDATION IN 2014 INCLUDED: GIANNI BONADONNA BREAST CANCER AWARD AND LECTURE- THIS AWARD RECOGNIZED AN ACTIVE CLINICAL OR TRANSLATIONAL RESEARCHER WITH A DISTINGUISHED RECORD OF ACCOMPLISHMENTS IN ADVANCING THE FIELD OF BREAST CANCER AS WELL AS EXCEPTIONAL MENTORING ABILITIES. THE AWARD WINNER GAVE A LECTURE DURING THE BREAST CANCER SYMPOSIUM. BJ KENNEDY AWARD AND LECTURE- THIS AWARD RECOGNIZED A GERIATRIC ONCOLOGIST WHO HAS DEMONSTRATED OUTSTANDING LEADERSHIP AND ACHIEVEMENT IN THE FIELD OF GERIATRIC ONCOLOGY. THE AWARD WINNER GAVE A LECTURE DURING THE ASCO ANNUAL MEETING. AMERICAN CANCER SOCIETY AWARD AND LECTURE - THIS AWARD RECOGNIZED AN ONCOLOGIST THAT HAS MADE A SIGNIFICANT CONTRIBUTION TO CANCER PREVENTION AND CONTROL RESEARCH OR PRACTICE. THE AWARD IS JOINTLY SUPPORTED BY THE AMERICAN CANCER SOCIETY. THE AWARD WINNER GAVE A LECTURE DURING THE ASCO ANNUAL MEETING. 3523274 2948100 QUALITY AND ACCESS TO CARE - REMARKABLE ADVANCES IN CANCER MEDICINE ARE OCCURRING MORE AND MORE FREQUENTLY, YET THE FULL PROMISE OF SUCH PROGRESS CANNOT BE REALIZED UNTIL HIGH-QUALITY CANCER CARE IS AVAILABLE TO EVERYONE. CCF IS KEENLY AWARE OF THE POTENTIALLY FATAL DIVIDE BETWEEN THOSE WITH ACCESS TO THE FRUITS OF RESEARCH AND TIMELY CARE AND THOSE WITHOUT. WE SEEK TO CONFRONT THESE DISPARITIES AND IMPROVE THE OUTLOOK FOR EVERY PERSON TOUCHED BY CANCER BY SUPPORTING PROGRAMS THAT INCREASE ACCESS TO CARE IN ALL COMMUNITIES, INCLUDING THOSE UNDERSERVED. THE QUALITY AND ACCESS TO CARE PROGRAMS AND INITIATIVES SUPPORTED BY CCF IN 2014 INCLUDE THE FOLLOWING: CANCERLINQ; CANCERLINQ IS A BIG DATA PROJECT THAT AIMS TO RAPIDLY IMPROVE THE OVERALL QUALITY OF CANCER CARE CANCERLINQ IS BASED ON A CUTTING-EDGE HEALTH IT PLATFORM THAT WILL POWERFULLY CONNECT AND ANALYZE REAL-WORLD CANCER CARE DATA FROM ALMOST ANY ELECTRONIC RECORD SOURCE. CANCERLINQ WILL BE ABLE TO : PROVIDE REAL-TIME QUALITY FEEDBACK TO PROVIDERS; UNCOVER PATTERNS THAT CAN IMPROVE CARE; FEED PERSONALIZED INSIGHTS TO DOCTORS. STATE/REGIONAL AFFILIATE PROGRAM - THE ASCO STATE/REGIONAL AFFILIATE PROGRAM IS DESIGNED TO ADDRESS ISSUES IN THE PRACTICE OF ONCOLOGY ON THE LOCAL LEVEL. THE PROGRAM INCLUDES FACILITATION OF INTERACTION AMONG ASCO AND 49 STATE OR REGIONAL ONCOLOGY SOCIETIES THAT HAVE ACCESS TO THE SOCIETY'S EXPERTISE AND GUIDANCE ON WAYS TO STRENGTHEN THEIR ORGANIZATIONS, ENHANCE THEIR EDUCATIONAL ACTIVITIES, AND PROVIDE ADVOCACY SUPPORT, EDUCATION AND RESOURCES ON PRACTICE-RELATED ISSUES, AND A WEBSITE DEVELOPMENT TOOL. DIVERSITY IN ONCOLOGY INITIATIVE - THE CCF GRANTS AND AWARDS PROGRAM PROVIDES FUNDING FOR DIFFERENT TYPES OF AWARD OPPORTUNITIES FOR ONCOLOGY FELLOWS, CLINICAL PRACTICES, AND INTERNATIONAL RESEARCHERS. ONE OF THE PROGRAMS OFFERED THROUGH CCF IS THE DIVERSITY IN ONCOLOGY INITIATIVE. THE DIVERSITY IN ONCOLOGY INITIATIVE WAS STRUCTURED TO FACILITATE THE RECRUITMENT AND RETENTION OF INDIVIDUALS FROM POPULATIONS UNDERREPRESENTED IN MEDICINE TO CANCER CAREERS, WITH PARTICULAR ATTENTION TO THE DEVELOPMENT OF CLINICAL PRACTITIONERS AND INVESTIGATORS. IN 2014, $81,500 PROVIDED TWO PROGRAMS FOR INDIVIDUALS INTERESTED OR CURRENTLY PRACTICING IN THE ONCOLOGY FIELD: MEDICAL STUDENT ROTATION - THE MEDICAL STUDENT ROTATION (MSR), PROVIDES 8- TO 10-WEEK CLINICAL OR CLINICAL RESEARCH ONCOLOGY ROTATIONS FOR U.S. MEDICAL STUDENTS FROM POPULATIONS UNDERREPRESENTED IN MEDICINE WHO ARE INTERESTED IN PURSUING ONCOLOGY AS A CAREER. IN 2014, $68,000 PROVIDED 8 MSRS. RESIDENT TRAVEL AWARD - THE RESIDENT TRAVEL AWARD PROVIDES FINANCIAL SUPPORT FOR RESIDENTS FROM UNDERREPRESENTED POPULATIONS TO ATTEND ASCO'S ANNUAL MEETING. THE INTENTION OF THIS AWARD IS TO ATTRACT RESIDENTS FROM UNDERREPRESENTED POPULATIONS TO A POSSIBLE CAREER IN ONE OF THE ONCOLOGY SPECIALTIES. THIS TRAVEL AWARD WILL ALLOW THE RECIPIENTS TO TRAVEL TO THE ASCO ANNUAL MEETING, WHERE THEY WILL HAVE AN OPPORTUNITY TO MEET ONCOLOGISTS AND TO UNDERSTAND THE CAREER POSSIBILITIES IN THE AREA. IN 2014, $13,500 FUNDED 9 RTAS.ALTHOUGH A NUMBER OF PROGRAMS EXIST TO RECRUIT INDIVIDUALS UNDERREPRESENTED IN MEDICINE, FEW OF THESE PROGRAMS FOCUS SPECIFICALLY ON RECRUITMENT TO CLINICAL ONCOLOGY. ULTIMATELY, IT IS HOPED THAT INCREASING DIVERSITY IN THE CLINICAL ONCOLOGY PROFESSION WILL LEAD TO INCREASED AND IMPROVED CANCER CARE FOR UNDERSERVED POPULATIONS AS WELL AS INCREASED RESEARCH ON HEALTH DISPARITIES. 616552 575900 19123637 true true false false false false false false false true false false false false true true true true false false true true true false false false false true true true false false false false false false false false true false false false false true false false false true 162 0 true 0 false false false false false true true false false false false X 16 15 false false true false false true true true true false false true true true true true true true true false AL AK AZ AR CA CO CT FL GA HI IL KS KY ME MD MA MI MN MS MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X ERIN HULTMAN FINANCE DIRECT 5714831300 2318 MILL ROAD STE 800 ALEXANDRIA VA 22314 W Charles Penley MD FASCO Chair 1.0 1.0 X X 0 0 0 Gabriel N Hortobagyi MD FACP Treasurer 1.0 0.0 X X 0 0 0 John H Glick MD FASCO Secretary 1.0 0.0 X X 0 0 0 Allen S Lichter MD FASCO CEO 4.0 33.5 X X 0 810390 20730 Nancy Daly MS MPH Executive Director 37.5 0.0 X X 0 259385 32795 Peter Yu MD FACP FASCO ASCO President 1.0 1.0 X X 0 0 0 Thomas Roberts Jr MD Board Member 1.0 0.0 X 0 0 0 Thomas Marsland MD FASCO Board Member 1.0 0.0 X 0 0 0 Lawrence H Einhorn MD FASCO Board Member 1.0 0.0 X 0 0 0 Michael Gordon JD Board Member 1.0 0.0 X 0 0 0 Claire Huang Board Member 1.0 0.0 X 0 0 0 Beth Karlan MD Board Member 1.0 0.0 X 0 0 0 Raj Mantena RPh Board Member 1.0 0.0 X 0 0 0 Robert Mayer MD FASCO Board Member 1.0 0.0 X 0 0 0 Martin Murphy DMedSc PhD FASCO Board Member 1.0 0.0 X 0 0 0 Steven Rosen MD FACP Board Member 1.0 0.0 X 0 0 0 Aaron Sasson Board Member 1.0 0.0 X 0 0 0 Sandra Swain MD FACP Board Member 1.0 0.0 X 0 0 0 Paul Aines CPA CFO 4.0 33.5 X 0 333500 36776 0 1403275 90301 0 false true false GOODWAY GROUP PO BOX 607 JENKINTOWN PA 19046 DIGITAL CAMPAIGN 187291 1 11886 2799996 33587564 43922 36399446 0 929857 929857 0 0 0 0 0 39121352 37773541 1347811 1347811 796521 0 0 0 0 38677114 1726378 15273257 15273257 345170 345170 329500 329500 0 0 0 0 0 0 0 3133025 1817155 281972 1033898 18454 18454 0 0 0 300153 300153 717627 413646 303981 0 38133 20086 18047 97312 178 75839 21295 0 252360 252360 246303 42798 175224 28281 0 137120 10672 85289 41159 0 0 0 0 POSTAGE 158010 132 21052 136826 DUES & SUBSCRIPTIONS 83486 75412 8074 BANK & CREDIT CARD FEES 26092 26092 ALLOCATION OF ADMIN OVERHEAD 1304774 -1332828 28054 21156002 19123636 412751 1619615 3786795 4133563 950756 0 8054407 20628991 0 0 0 0 0 0 0 0 0 0 48136 84659 0 34203217 39653197 0 0 0 0 0 0 0 0 47043311 64500410 3804205 4168909 0 0 686647 747685 0 0 0 0 0 0 0 0 0 0 513356 574891 5004208 5491485 X 28184088 30285400 9930574 24789334 3924441 3934191 42039103 59008925 47043311 64500410 X 17521112 -551290 X false true X true false X 24400007 23206830 25403476 24662684 36399446 134072443 0 0 24400007 23206830 25403476 24662684 36399446 134072443 58097955 75974488 136059 595807 925185 927924 929857 3514832 0 0 137587275 0.55219 0.66450 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 4031095 9750 110331 182200 3968976 2605326 1320000 107969 2200 4031095 82699 2517200 7627 2200 2605326 82241 5000 -2594 1948 82699 116963 15930 1348 52000 82241 1.00000 false false 0 DUE TO RELATED ORGANIZATION 574891 574891 X 37825671 -551290 -551290 38376961 300153 300153 38677114 20855849 20855849 300153 300153 21156002 PART V, LINE 4 Permanently restricted net assets of donor-restricted endowment funds are preserved, absent explicit direction from the donor. Interest from the permanently restricted funds is intended to fund future research and/or educational awards. PART V, LINE 1A-1G ENDOWMENT FUNDS ARE BASED ON GAAP AND AGREE TO THE RESTRICTED FUNDS ON THE AUDITED FINANCIAL STATEMENTS. PART X, LINE 2 UNDER ASC TOPIC 740-10, ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES, THE FOUNDATION MAY RECOGNIZE THE TAX BENEFIT FROM AN UNCERTAIN TAX POSITION ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITION WILL BE SUSTAINED AN EXAMINATION BY TAXING AUTHORITIES, BASED ON THE TECHNICAL MERITS OF THE POSITION. THE TAX BENEFITS RECOGNIZED IN THE FINANCIAL STATEMENTS FROM SUCH A POSITION ARE MEASURED BASED ON THE LARGEST BENEFIT THAT HAS A GREATER THAN 50% LIKELIHOOD OF BEING REALIZED UPON ULTIMATE SETTLEMENT. THE FOUNDATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR TAX POSITIONS TAKEN, AND THEREFORE, DOES NOT HAVE UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS. GENERALLY, THE FOUNDATION IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY THE U.S. FEDERAL, STATE OR LOCAL TAX AUTHORITIES FOR YEARS BEFORE DECEMBER 31, 2010. true East Asia and the Pacific Program Services AWARD & GRANTS 29000 Europe (Including Iceland and Greenland) Program Services AWARD & GRANTS 122400 North America Program Services AWARD & GRANTS 130100 South America Program Services AWARD & GRANTS 26000 South Asia Program Services AWARD & GRANTS 2000 Sub-Saharan Africa Program Services AWARD & GRANTS 20000 329500 329500 Europe (Including Iceland and Greenland) YOUNG INVESTIGATOR AWARD 50000 CASH/CHECK North America Young Investigator Awards 100000 CASH/CHECK East Asia and the Pacific INTERNATIONAL INNOVATION GRANT 20000 CASH/CHECK Europe (Including Iceland and Greenland) Gianni Bonadonna Breast Cancer Research Fellowship 50000 CASH/CHECK Sub-Saharan Africa International Innovation Grant 20000 CASH/CHECK South America International Innovation Grant 20000 CASH/CHECK 6 AWARDS East Asia and the Pacific 9 9000 CASH/CHECK AWARDS Europe (Including Iceland and Greenland) 21 22400 CASH/CHECK AWARDS North America 27 30100 CASH/CHECK AWARDS South America 6 6000 CASH/CHECK AWARDS South Asia 2 2000 CASH/CHECK false false false false false false PART I, LINE 2: EXPLANATION: CCF GRANTS ARE AWARDED BASED ON MERIT THROUGH A PEER-REVIEW PROCESS CONDUCTED BY MEMBERS OF CCF'S GRANT SELECTION COMMITTEE USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH SPECIFIC GRANT. GRANTEES ARE REQUIRED TO SIGN A GRANT AGREEMENT WITH CCF THAT ESTABLISHES CERTAIN REQUIREMENTS FOR THE GRANT. GRANTEES MUST REQUEST CCF'S APPROVAL FOR ANY CHANGES IN THE GRANT PROJECT AND THE GRANTEE'S STATUS. GRANTEES MUST SUBMIT A FORMAL REQUEST FOR A CHANGE IN OBJECTIVES OR SCOPE TO CCF AND INCLUDE JUSTIFICATION FOR THE CHANGES, WHICH IS SUBJECT TO CCF'S REVIEW AND APPROVAL. GRANTEES ARE REQUIRED TO NOTIFY CCF AND REQUEST A NO-COST EXTENSION IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT OR TO MEET THE PROPOSED TIME SCHEDULES. GRANTEES ARE REQUIRED TO NOTIFY CCF IF THEY PLAN TO LEAVE AN ORGANIZATION DURING THE COURSE OF A GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. CHANGES OF GREATER THAN 5% OF THE TOTAL YEARLY GRANT BUDGET BETWEEN OR INTO NEW BUDGET CATEGORIES ARE SUBJECT TO THE REVIEW AND APPROVAL OF CCF. CCF REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (FINANCIAL REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND A BUDGET SUMMARY ARE REQUIRED TO BE SUBMITTED WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING THE END OF THE GRANT BUDGET PERIOD. CCF REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. CCF REQUIRES A FINAL PROJECT REPORT AND BUDGET SUMMARY WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING EXPIRATION OF THE GRANT. CCF REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED TO CCF. GRANTS ARE ADMINISTRATIVELY CLOSED BY CCF AFTER RECEIPT OF THE FINAL PROJECT REPORT AND FINAL BUDGET SUMMARY AND AFTER CCF'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS IN THE GRANT HAVE BEEN MET. CCF RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENTLY WITH THE APPROVED BUDGET. true Baylor College of Medicine One Baylor Plaza Houston TX 77030 741613878 501(C)(3) 250000 YIA Beth Israel Deaconess Medical Center 330 Brookline Avenue Boston MA 22150 135564934 501(C)(3) 50000 YIA Case Western Reserve University 11100 Euclid Ave Cleveland OH 441065065 341018992 501(C)(3) 200000 CDA City of Hope 1500 East Duarte Road Duarte CA 910103000 951683875 501(C)(3) 50000 YIA Columbia University Medical Center 630 West 168th Street New York NY 10032 135598093 501(C)(3) 50000 YIA Dana-Farber Cancer Institute 44 Binney Street Boston MA 21150 422630400 501(C)(3) 600000 CDA, YIA David Geffen School of Medicine at UCLA 10833 Le Conte Ave Los Angeles CA 90095 954373071 501(C)(3) 50000 YIA Emory University 201 Dowman Drive Atlanta GA 30322 580566256 501(C)(3) 50000 YIA Fred Hutchinson Cancer Research Center 1100 Fairview Ave N Seattle WA 98109 237156071 501(C)(3) 50000 YIA George Washington University George Washington University Washington DC 20037 530196584 501(C)(3) 8500 MSRA H Lee Moffitt Cancer Center and Research Institut 12902 Magnolia Drive MCC-CEO Tampa FL 336129497 592451713 501(C)(3) 50000 YIa Harvard Medical School 25 Shattuck Street Boston MA 02115 042103580 501(C)(3) 8500 msra Indiana University 420 University Boulevard Indianapolis IN 46202 135601673 501(C)(3) 200000 CDA Johns Hopkins University 401 North Broadway Baltimore MD 21231 521479934 501(C)(3) 100000 YIA Levine Cancer Institute 1021 Morehead Medical Dr Charlotte NC 28204 560529945 501(C)(3) 50000 YIA Massachusetts General Hospital 55 Fruit Street Boston MA 021142696 426979830 501(C)(3) 50000 YIA Meharry Medical College 1005 Dr DB Todd Jr Blvd Nashville TN 37208 620488046 501(C)(3) 8500 MSRA Memorial Sloan Kettering Cancer Center 1275 York Avenue New York NY 10065 131624182 501(C)(3) 1265000 cda, ltif, YIA Montefiore Medical Center 111 East 210th Street Bronx NY 10467 131740114 501(C)(3) 50000 yia National Cancer Institute (NIHNCI) National Cancer Institute Bethesda MD 20892 541843091 501(C)(3) 100000 yia New York University School of Medicine 550 1st Ave New York NY 10016 135562309 501(C)(3) 50000 yia Stanford University 800 Welch Road Stanford CA 943055796 941156365 501(C)(3) 150000 yia The Children's Hospital of Philadelphia 34th Street and Civic Center Boulev Philadelphia PA 191044399 231352166 501(C)(3) 100000 yia The Ohio State University 300 W 10th Ave Columbus OH 43210 911825354 501(C)(3) 365000 cda, yia, LTIF The University of Chicago 5841 South Maryland Avenue Chicago IL 606371470 362177139 501(C)(3) 100000 yia The University of Texas MD Anderson Cancer Center 1515 Holcombe Boulevard Houston TX 77030 174600118 501(C)(3) 265000 LTIF, cda University of Alabama at Birmingham 1802 Sixth Avenue South Birmingham AL 352943300 636005396 501(C)(3) 50000 yia University of California San Francisco 2340 Sutter Street San Francisco CA 941150128 946036493 501(C)(3) 58500 MSRA, yia University of Cincinnati 2600 Clifton Avenue Cincinnati OH 45221 316000989 501(C)(3) 8500 msra University of Colorado Cancer Center 13001 E 17th Place Aurora CO 80045 846000555 501(C)(3) 50000 yia University of Illinois at Chicago 1737 West Polk Street Chicago IL 60612 376000511 501(C)(3) 8500 msra University of Illinois College of Medicine at Peor 520 NE Glen Oak Ave Peoria IL 61637 376000511 501(C)(3) 50000 yia University of Massachusetts Medical School 55 Lake Avenue North Worcester MA 16550 043167352 501(C)(3) 8500 msra University of Michigan 1500 E Medical Center Drive Ann Arbor MI 48109 386006309 501(C)(3) 150000 yia University of Pennsylvania 16th Floor Penn Tower Philadelphia PA 191044283 231352685 501(C)(3) 100000 yia University of Tennessee Health Sciences Center 920 Madison Ave Memphis TN 38163 626001636 501(C)(3) 50000 yia Vanderbilt University Medical Center 691 Preston Research Building Nashville TN 381053678 620476822 501(C)(3) 500000 ACRA, YIA Veterans Affairs Greater Los Angeles 11301 Wilshire Blvd Los Angeles CA 90013 454968654 501(C)(3) 200000 CDA Washington University in Saint Louis 660 S Euclid Ave St Louis MO 63110 556000842 501(C)(3) 50000 yia American Society of Clinical Oncology 2318 Mill Rd 800 Alexandria VA 22314 136180380 501(C)(3) 9718757 Contribution 40 GIANNI BONADONNA BREAST CANCER FELLOWSHIP 1 10000 MERIT AWARDS 100 109400 PATIENT ADVOCATE SCHOLARSHIPS 111 181850 ONCOLOGY TRAINEE TRAVEL AWARDS 36 43920 PART I, LINE 2 CCF GRANTS ARE AWARDED BASED ON MERIT THROUGH A PEER-REVIEW PROCESS CONDUCTED BY MEMBERS OF CCF'S GRANT SELECTION COMMITTEE USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH SPECIFIC GRANT. GRANTEES ARE REQUIRED TO SIGN A GRANT AGREEMENT WITH CCF THAT ESTABLISHES CERTAIN REQUIREMENTS FOR THE GRANT. GRANTEES MUST REQUEST CCF'S APPROVAL FOR ANY CHANGES IN THE GRANT PROJECT AND THE GRANTEE'S STATUS. GRANTEES MUST SUBMIT A FORMAL REQUEST FOR A CHANGE IN OBJECTIVES OR SCOPE TO CCF AND INCLUDE jUSTIFICATION FOR THE CHANGES, WHICH IS SUBJECT TO CCF'S REVIEW AND APPROVAL. GRANTEES ARE REQUIRED TO NOTIFY CCF AND REQUEST A NO-COST EXTENSION IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT OR TO MEET THE PROPOSED TIME SCHEDULES. GRANTEES ARE REQUIRED TO NOTIFY CCF IF THEY PLAN TO LEAVE AN ORGANIZATION DURING THE COURSE OF A GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. CHANGES OF GREATER THAN 5% OF THE TOTAL YEARLY GRANT BUDGET BETWEEN OR INTO NEW BUDGET CATEGORIES ARE SUBJECT TO THE REVIEW AND appROVAL OF CCF. CCF REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (FINANCIAL REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND A BUDGET SUMMARY ARE REQUIRED TO BE SUBMITTED WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING THE END OF THE GRANT BUDGET PERIOD. CCF REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. CCF REQUIRES A FINAL PROJECT REPORT AND BUDGET SUMMARY WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING EXPIRATION OF THE GRANT. CCF REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED TO CCF. GRANTS ARE ADMINISTRATIVELY CLOSED BY CCF AFTER RECEIPT OF THE FINAL PROJECT REPORT AND FINAL BUDGET SUMMARY AND AFTER CCF'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS IN THE GRANT HAVE BEEN MET. CCF RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENTLY WITH THE APPROVED BUDGET. part II, award abbreviations: YIA: Young investigator award CDA: Career Development award MSRA: medical student rotation award LTIF: long-term international fellowship ACRA: advanced clinical research false false false false false false false false false Allen S Lichter MD FASCO CEO 0 671390 0 79000 0 60000 0 19500 0 1230 0 831120 0 0 Nancy Daly MS MPH Executive Director 0 249385 0 10000 0 0 0 19454 0 13341 0 292180 0 0 Paul Aines CPA CFO 0 321500 0 12000 0 0 0 19500 0 17276 0 370276 0 0 PART I, LINE 3: EXPLANATION: COMPENSATION IS ESTABLISHED BY A RELATED ORGANIZATION, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. THE METHODS USED BY ASCO TO DETERMINE COMPENSATION ARE: COMPENSATION COMMITTEE; INDEPENDENT COMPENSATION CONSULTANT; FORMS 990 OF OTHER ORGANIZATIONS, WRITTEN EMPLOYMENT CONTRACT; COMPENSATION STUDY OR SURVEY; AND APPROVAL BY BOARD OR COMPENSATION COMMITTEE. X 3 43922 PUBLICLY TRADED VAL false true false FORM 990, PART III, LINE 4D OTHER PROGRAM SERVICES: PATIENT EDUCATION AND INFORMATION - WELL-INFORMED, EDUCATED PATIENTS ARE THEIR OWN BEST ADVOCATES, AS WELL AS INVALUABLE PARTNERS FOR DOCTORS. CCF SUPPORTS PROGRAMS AND ACCURATE, DOCTOR-APPROVED CANCER INFORMATION AND RESOURCES BOTH IN PRINT AND ONLINE, THAT EDUCATE PATIENTS AND THE PUBLIC ABOUT CANCER CARE, TREATMENT, RESEARCH,PREVENTION, AND OTHER ISSUES IMPORTANT TO THE CANCER COMMUNITY. FUNDING IN THIS AREA ALLOWS CCF TO CONTINUE AND EXPAND OUR WORK TO INFORM PATIENTS. HIGHLIGHTS OF PATIENT EDUCATION AND INFORMATION PROGRAMS AND ACTIVITIES SUPPORTED BY CCF IN 2014 INCLUDE THE FOLLOWING: PATIENT ADVOCATE SCHOLARSHIP PROGRAM- THE PATIENT ADVOCATE SCHOLARSHIP PROGRAM PROVIDES TRAVEL GRANTS TO A SELECT NUMBER OF PATIENT ADVOCATES TO ATTEND THE ASCO ANNUAL MEETING AND COSPONSORED THEMATIC MEETINGS. IN 2014, $181,850 IN FUNDING ALLOWED 111 PATIENT ADVOCATES TO ATTEND THE ASCO ANNUAL MEETING AND COSPONSORED THEMATIC MEETINGS. CANCER.NET- CANCER.NET BRINGS THE EXPERTISE AND RESOURCES OF ASCO TO PEOPLE LIVING WITH CANCER AND THOSE WHO CARE FOR AND CARE ABOUT THEM. THE WEBSITE PROVIDES TIMELY, COMPREHENSIVE INFORMATION TO HELP PATIENTS AND FAMILIES MAKE INFORMED HEALTH CARE DECISIONS ALL CONTENT IS SUBJECT TO A FORMAL PEER-REVIEW PROCESS BY THE CANCER.NET EDITORIAL BOARD, COMPOSED OF MORE THAN 150 MEDICAL, SURGICAL, RADIATION, AND PEDIATRIC ONCOLOGISTS, PHYSICIAN ASSISTANTS, ONCOLOGY NURSES, SOCIAL WORKERS, AND PATIENT ADVOCATES AND INCLUDES PEER-REVIEWED INFORMATION ON MORE THAN 124 TYPES OF CANCER AND SYNDROMES, INCLUDING RISK FACTORS, DIAGNOSIS, FINDING AN ONCOLOGIST, TREATMENT, MANAGING SIDE EFFECTS, CLINICAL TRIALS, AND AFTER TREATMENT, CAREGIVING, COPING STRATEGIES, AND SURVIVORSHIP. INFORMATION IS DELIVERED IN WRITTEN ARTICLES, VIDEOS, AND AUDIO PODCASTS. THIS INFORMATION IS MADE AVAILABLE FREE TO THE PUBLIC. IN 2014, THERE WERE MORE THAN 7,000,000 VISITS AND MORE THAN 16,000,000 PAGE VIEWS OF CANCER.NET. CCF CONTINUES TO SUPPORT THE PRODUCTION OF ASCO'S PRINTED PATIENT EDUCATION MATERIALS-KNOWN COLLECTIVELY AS ASCO ANSWERS, THESE MATERIALS COMBINE QUALITY INFORMATION, A CONVERSATIONAL TONE, AND A REASSURING LOOK AND FEEL TO GIVE PATIENTS AND THEIR CAREGIVERS THE CONFIDENCE THEY NEED TO BECOME ACTIVE PARTICIPANTS IN THEIR CANCER CARE. IN 2014 THE ASCO ANSWERS SERIES INCLUDED MATERIALS SUPPORTED BY CCF SUCH AS: ASCO ANSWERS FACT SHEETS- ASCO ANSWERS IS A SERIES OF FACT SHEETS THAT PROVIDE AN INTRODUCTION TO A SPECIFIC TYPE OF CANCER OR CANCER-RELATED TOPIC. CURRENT DISEASE-SPECIFIC FACT SHEETS INCLUDE: BREAST, COLORECTAL, LUNG, AND PROSTATE CANCERS AND ARE ALSO AVAILABLE IN SPANISH. EACH FACT SHEET INCLUDES AN OVERVIEW OF THE SUBJECT, TERMS TO KNOW, AND QUESTIONS TO ASK THE DOCTOR. ASCO ANSWERS PATIENT GUIDES- PATIENT GUIDES ARE PRINTED BOOKLETS CONTAINING COMPREHENSIVE CANCER INFORMATION; INCLUDING AN OVERVIEW OF SPECIFIC CANCER TYPES, SYMPTOMS, DIAGNOSIS, STAGING, TREATMENT, CLINICAL TRIALS, AND AFTER TREATMENT. ONCOLOGY PROFESSIONALS AND PATIENTS EXPLORE THESE CANCER-SPECIFIC BOOKLETS TOGETHER AFTER A DIAGNOSIS OF CANCER. THERE ARE BOOKLETS FOR THE FOUR MOST COMMON TYPES OF CANCER IN THE UNITED STATES: BREAST, COLORECTAL, LUNG, PROSTATE AND ARE AVAILABLE IN ENGLISH AND SPANISH. IN 2014 THE FOUNDATION ALSO HELPED TO SUPPORT THE CREATION OF BOOKLETS ON CANCER SURVIVORSHIP AND PALLIATIVE CARE. INTERNATIONAL PROGRAMS - ASCO AND THE CONQUER CANCER FOUNDATION SHARE AN INTERNATIONAL MISSION TO ENGAGE THE PHYSICIAN AND THE HEALTHCARE PROFESSIONAL COMMUNITY ON A GLOBAL SCALE TO IMPROVE CARE TO CANCER PATIENTS AND ENHANCE THE EXCHANGE OF KNOWLEDGE TO FACILITATE ADVANCES IN THE CARE OF PEOPLE WITH CANCER EVERYWHERE. CCF FUNDS SUPPORT INTERNATIONAL PROGRAMS INCLUDING EDUCATION, FELLOWSHIP AND GRANT OPPORTUNITIES TO ENABLE ONCOLOGISTS FROM OPPOSITE ENDS OF THE WORLD TO SHARE IDEAS AND BUILD LASTING COLLABORATIONS THAT CAN ENHANCE PATIENT CARE LOCALLY AND GLOBALLY. CCF SUPPORTS THESE PROGRAMS THROUGH ITS INTERNATIONAL PROGRAM MISSION AS WELL AS THROUGH CCF'S OTHER MISSION AREAS (RESEARCH, PROFESSIONAL EDUCATION, PATIENT EDUCATION AND INFORMATION AND QUALITY AND ACCESS TO CARE). CCF FUNDS SPECIFICALLY SUPPORTING INTERNATIONAL ACTIVITIES INCLUDE THE FOLLOWING: LONG-TERM INTERNATIONAL FELLOWSHIP (LTIF) PROVIDES EARLY-CAREER ONCOLOGISTS IN DEVELOPING NATIONS THE SUPPORT AND RESOURCES NEEDED TO ADVANCE THEIR TRAINING BY DEEPENING THEIR RELATIONSHIP WITH A UNITED STATES OR CANADIAN COLLEAGUE AND HIS OR HER INSTITUTION. THROUGH A ONE YEAR FELLOWSHIP THE RECIPIENT WILL EARN VALUABLE TRAINING AND EXPERIENCE WITH WHICH THEY CAN AFFECT CHANGE IN CANCER CARE IN THEIR HOME COUNTRY. RECIPIENTS MUST RETURN TO THEIR HOME INSTITUTIONS AFTER COMPLETING THEIR FELLOWSHIP AND ARE EXPECTED TO DISSEMINATE THE KNOWLEDGE THEY HAVE GAINED. INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD (IDEA)-THE INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD PROVIDES SUPPORT FOR ONCOLOGISTS IN DEVELOPING COUNTRIES TO PARTICIPATE IN THE ASCO ANNUAL MEETING AND VISIT A CANCER CENTER IN THE UNITED STATES OR CANADA. THIS AWARD WAS DESIGNED TO PROVIDE CONTINUING MEDICAL EDUCATION, ASSIST IN CAREER DEVELOPMENT AND HELP TO ESTABLISH STRONG RELATIONSHIPS WITH LEADING ASCO MEMBERS WHO SERVE AS SCIENTIFIC MENTORS TO EACH RECIPIENT. INTERNATIONAL INNOVATION GRANT (IIG) PROVIDES RESEARCH FUNDING IN SUPPORT OF NOVEL AND INNOVATIVE PROJECTS THAT CAN HAVE A SIGNIFICANT IMPACT ON CANCER CONTROL IN LOW- AND MIDDLE-INCOME COUNTRIES (LMCS). THE INTERNATIONAL INNOVATION GRANT PROGRAM IS INTENDED TO SUPPORT PROPOSALS OF UP TO $20,000 EACH THAT HAVE THE POTENTIAL TO REDUCE THE CANCER BURDEN IN LOCAL COMMUNITIES, WHILE ALSO BEING POTENTIALLY TRANSFERRABLE TO OTHER LOW- OR MIDDLE- INCOME SETTINGS. ADVANCED CANCER COURSES (ACC)-THE ADVANCED CANCER COURSES ARE CAREFULLY DESIGNED TO FILL THE NEED FOR ADVANCED LEARNING FOR INTERNATIONAL ONCOLOGISTS. THESE COURSES CAN BE CHOSEN FROM ASCO'S PORTFOLIO OF EDUCATIONAL PRODUCTS, OR DEVELOPED WITH THE COLLABORATION OF VOLUNTEER ONCOLOGISTS. MULTIDISCIPLINARY CANCER MANAGEMENT COURSES- MANY PATIENTS WITH CANCER AROUND THE WORLD SUFFER FROM LACK OF ACCESS TO CANCER SPECIALISTS. THIS NEED IS ACUTE IN LOW-TO-MIDDLE INCOME COUNTRIES WHERE LACK OF RESOURCES RESULT IN LARGE PATIENT LOADS, STRETCHED FACILITIES AND INADEQUATE SUPPORT FOR ONCOLOGISTS. ASCO INTERNATIONALS MULTIDISCIPLINARY CANCER MANAGEMENT COURSES (MCMCS) TEACH THE VALUE OF INTERDISCIPLINARY MANAGEMENT OF CANCER TO ACHIEVE OPTIMAL OUTCOMES FOR PATIENTS. THE COURSES PROVIDE FUNDAMENTAL TRAINING FOR PHYSICIANS, NURSES, PATHOLOGISTS AND RESIDENTS IN COUNTRIES WHERE PATIENTS WITH CANCER ARE FREQUENTLY SEEN BY NON-SPECIALISTS. MCMCS TEACH MULTIDISCIPLINARY MANAGEMENT OF THE MOST PREVALENT CANCER TYPES IN THE HOST COUNTRY AND CENTER THE LEARNING ON PATIENTS. CONTENT AND TOPICS ARE TAILORED BASED ON THE NEEDS AND INTEREST OF EACH AUDIENCE AND CAN INCLUDE BREAST, COLON, ANAL CANAL, RECTAL, LUNG, PROSTATE AND HEAD AND NECK CANCERS, AMONG OTHERS. SINCE 2004, NEARLY 3,000 CLINICIANS AND HEALTH CARE WORKERS HAVE PARTICIPATED IN THESE COURSES. IN OVERALL COURSE EVALUATIONS, 70% OF PARTICIPANTS HAVE REPORTED CHANGING PRACTICE AND 87% OF PARTICIPANTS ARE MORE CONFIDENT IN THEIR CARE OF PATIENTS. FORM 990, PART VI, SECTION A, LINE 1 AS OF DECEMBER 31, 2014, THE BOARD OF DIRECTORS OF CCF INCLUDED SIXTEEN (16) DIRECTORS WITH VOTING RIGHTS AND TWO (2) DIRECTORS WITHOUT VOTING RIGHTS. FIFTEEN (15) DIRECTORS WITH VOTING RIGHTS WERE APPOINTED BY THE BOARD OF DIRECTORS OF ASCO, A NON-PROFIT, 501(C)(3) TAX-EXEMPT RELATED ORGANIZATION. THERE WERE THREE EX-OFFICIO DIRECTORS: THE CHIEF EXECUTIVE OFFICER (CEO) (WITH VOTING RIGHTS), THE ASCO PRESIDENT (WITHOUT VOTING RIGHTS) AND THE EXECUTIVE DIRECTOR (WITHOUT VOTING RIGHTS). ALL VOTING MEMBERS OF THE BOARD OF DIRECTORS HAVE THE SAME VOTING RIGHTS. DURING THE REPORTED TAX YEAR, THE BOARD OF DIRECTORS DELEGATED AUTHORITY TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS CONSISTENT WITH CCFS BYLAWS. THE EXECUTIVE COMMITTEE IS COMPOSED OF THE CHAIR, CEO, SECRETARY, TREASURER, AND A FIFTH EXECUTIVE COMMITTEE MEMBER ELECTED BY THE DIRECTORS. ALL EXECUTIVE COMMITTEE MEMBERS ARE MEMBERS OF CCF'S BOARD OF DIRECTORS. THE SCOPE OF THE EXECUTIVE COMMITTEE'S AUTHORITY IS ESTABLISHED BY CCF'S BYLAWS, WHICH PROVIDE THAT EXCEPT TO THE EXTENT SPECIFICALLY PROHIBITED BY RESOLUTION OF THE BOARD OF DIRECTORS OR OTHERWISE PROHIBITED BY LAW AND EXCEPT AS SPECIFIED IN THE BYLAWS, THE EXECUTIVE COMMITTEE OF THE BOARD IS EMPOWERED TO MAKE AND IMPLEMENT DECISIONS BETWEEN BOARD MEETINGS AND IT MAY ACT ON ITEMS REQUIRING ACTION PRIOR TO THE NEXT ANNOUNCED BOARD MEETING. ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO THE BOARD OF DIRECTORS AT THE MEETING OF THE BOARD OF DIRECTORS IMMEDIATELY FOLLOWING THE ACTION TAKEN BY THE EXECUTIVE COMMITTEE, CONSISTENT WITH CCF'S BYLAWS. FORM 990, PART VI, SECTION A, LINE 4 CCF ADOPTED AMENDMENTS TO ITS BYLAWS IN 2014 TO COMPLY WITH REQUIREMENTS IMPLEMENTED BY THE NEW YORK NONPROFIT REVITALIZATION ACT. THE AMENDMENTS INCLUDED SEPARATING THE EVALUATION AND AUDIT COMMITTEE INTO TWO COMMITTEES, THE EVALUATION COMMITTEE AND THE AUDIT COMMITTEE, AND REVISING THE COMPOSITION OF THE AUDIT COMMITTEE SUCH THAT THE TREASURER MAY NOT BE CHAIR OF THE AUDIT COMMITTEE. THE AMENDMENTS ALSO LIST DUTIES THAT MUST BE PERFORMED BY THE AUDIT COMMITTEE UNDER NEW YORK LAW. THE AMENDMENTS WERE APPROVED BY THE BOARD OF DIRECTORS OF ASCO, AS REQUIRED BY THE CCF BYLAWS. FORM 990, PART VI, SECTION A, LINE 7A CCF DOES NOT HAVE MEMBERS. DIRECTORS OF CCF ARE APPOINTED AND SUBJECT TO REMOVAL BY THE BOARD OF DIRECTORS OF ASCO, EXCEPT FOR DIRECTORS SERVING EX-OFFICIO. FORM 990, PART VI, SECTION A, LINE 7B THE BOARD OF DIRECTORS OF CCF MAY VOTE TO AMEND OR REPEAL THE BYLAWS OF CCF, BUT THE BOARD OF DIRECTORS OF ASCO MUST APPROVE AN AMENDMENT OR REPEAL OF THE BYLAWS TO BE EFFECTIVE. CCF MAY NOT AMEND ITS ARTICLES OF INCORPORATION WITHOUT PROVIDING TO ASCO WRITTEN NOTICE OF THE PROPOSED AMENDMENT AT LEAST THIRTY (30) DAYS IN ADVANCE. FORM 990, PART VI, SECTION B, LINE 11 AN ELECTRONIC COPY OF THE CCF FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE CCF FINANCE COMMITTEE AND WAS DISCUSSED AT A MEETING OF THE FINANCE COMMITTEE BEFORE IT WAS FILED. AN ELECTRONIC COPY OF THE CCF FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS BEFORE IT WAS FILED. THE CCF FORM 990 WAS REVIEWED BY THE CHIEF FINANCIAL OFFICER, THE EXECUTIVE DIRECTOR, THE CEO, AND THE GENERAL COUNSEL PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C CCF MAINTAINS A NUMBER OF WRITTEN CONFLICT OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL CCF STAFF, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND ANY PERSON IN A RELATIONSHIP WITH THESE INDIVIDUALS INVOLVING THE SHARING OF INCOME OR ASSETS (E.G., SPOUSE, DEPENDENT CHILDREN). UNDER CCF'S POLICIES, COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS,CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE, AND UPDATED WHEN ANY MATERIAL CHANGES OCCUR. In addition, CCF officers, directors, and key employees are required to disclose annually business relationships or any transactions they or their related entities or family members have with CCF or with other officers, directors or key employees. CCF'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, WHEN CCF IS CONTEMPLATING ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY "INTERESTED PERSON" (I.E., A CCF DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF A COMMITTEE WITH BOARD DELEGATED POWERS WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERNATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 THE FOLLOWING EMPLOYEES OF ASCO SERVE AS OFFICERS OF CCF: CEO OF CCF (ALSO SERVES AS CEO OF ASCO) EXECUTIVE DIRECTOR OF CCF CFO OF CCF (ALSO SERVES AS CFO OF ASCO) GENERAL COUNSEL OF CCF (ALSO SERVES AS VP/GENERAL COUNSEL OF ASCO) INFORMATION REGARDING THEIR COMPENSATION AND THE PROCESS FOR DETERMINING THEIR COMPENSATION ARE DESCRIBED IN THE IRS FORM 990 OF ASCO. CCF STAFF ARE EMPLOYEES OF ASCO WHO ARE LEASED TO CCF. APPLICABLE INFORMATION REGARDING THEIR COMPENSATION IS DESCRIBED IN THE IRS FORM 990 OF ASCO. CCF DOES NOT PAY COMPENSATION TO THESE INDIVIDUALS. FORM 990, PART VI, SECTION C, LINE 19 CCF'S GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC FROM CCF UPON REQUEST. CCF'S ARTICLES OF INCORPORATION ARE ALSO AVAILABLE TO THE PUBLIC THROUGH THE VIRGINIA STATE CORPORATION COMMISSION. CONFLICT OF INTEREST POLICIES AND STANDARDS ARE POSTED ON CCF'S WEBSITE. THE ANNUAL REPORT OF CCF IS POSTED ON CCF'S WEBSITE AND IS AVAILABLE TO THE PUBLIC FROM CCF UPON REQUEST. THE AUDITED FINANCIAL STATEMENTS OF CCF ARE POSTED ON CCF'S WEBSITE. AMERICAN SOCIETY OF CLINICAL ONCOLOGY 2318 MILL RD 800 ALEXANDRIA VA 22314 136180380 education NY 501C3 LINE 9 false false true true true false false false false false false true true false true true true true false false